The blood supply chain starts with the blood donor and ends with the patient, but ultimately it is the requirement for blood by the patient that drives the chain and hence the number of blood donations required. Various factors affect the blood supply chain; the number of donors who are willing to donate regularly, seasonal factors affecting donation e.g. public holidays, the blood services ability to adequately predict the number of units of blood required throughout the year and to ensure that they do not overstock and therefore increase wastage, the clinicians' awareness of appropriate blood ordering and transfusion and the hospital laboratories ability to ensure sufficient stock yet have minimal wastage. It is essential that all staff working in each area of the blood supply chain is aware of their responsibilities to ensure minimal wastage of this freely given resource. Therefore education and training and data collection are important elements of the blood supply chain.
Current Leadership
Rada M. Grubovic Rastvorceva
Assoc. Prof. Dr. Rada Milos Grubovic Rastvorceva, MD MSci PhD is Consultant in Transfusion Medicine and Hematology, Scientific Program Manager at European Directorate for the Quality of Medicines and HealthCare (EDQM) at the Council of Europe, Strasbourg, France and Associate Professor at the Faculty of Medical Sciences at Goce Delcev University, Stip, N. Macedonia. Dr. Grubovic has been President of Macedonian Society for Transfusion Medicine and Chief Medical Officer of Institute for Transfusion Medicine of RNM in Skopje, N. Macedonia. Dr. Grubovic was awarded with Princes of Wales Memorial Award by the British Blood Transfusion Society, Fulbright Scholarship by the US Department of State, Award for Scientific Contribution in the Field of Medical Sciences and Certificate of Recognition for Scientific Productivity by the Faculty of Medical Sciences, University Goce Delcev, Stip, N. Macedonia, Certificate of Recognition from Macedonian Medical Association and many other domestic and international recognitions. She has more than 20 years working experience in the transfusion medicine field and extensive research experience in blood donation, apheresis, blood safety and supply, cellular therapy, transplantation medicine, clinical transfusion, quality management and etc. She gained additional research experience at University of California Los Angeles (UCLA), USA and King’s College Hospital, London, UK. She was National Project Manager of the EU IPA project “Strengthening of the Blood Safety System” 2013/14 and collaborator of European Blood Alliance (EBA) at EU projects SUPPORT-E and SUPPLY. Dr. Grubovic was a national representative in European Committee on Blood Transfusion at EDQM, Council of Europe and in European Commission on SoHO (bilateral screening chapter 28) and institutional representative and board member of EBA. She was advisor of Macedonian Minister of Health 2012-2015 and was a founder and Project Leader of National COVID-19 convalescent plasma program (PI – trial NCT04397523). She participated in numerous research projects and authored and coauthored more than 250 scientific publications. Dr. Grubovic is a member of ISBT, AABB, ISCT, MMA, MMC, MSTM and editorial board member and reviewer in more than 20 international medical journals.
https://www.linkedin.com/in/radicagrubovic/
email: [email protected]
Demewoz Tadesse
Over the course of my career, I have demonstrated a proven track record in delivering exceptional results. I have provided clinical consultation to healthcare providers and blood bank staff, ensuring the highest standards of care are maintained. By leveraging my expertise, I have successfully supported maternal and child health programs at different tiers of the healthcare system, effectively mitigating maternal death rates.
My ability to lead and manage teams has been instrumental in achieving these outcomes. I possess strong leadership skills that enable me to motivate and inspire others towards a common goal. With an emphasis on collaboration and effective communication, I have fostered positive relationships with colleagues and stakeholders alike.
Furthermore, my analytical skills allow me to assess complex situations quickly and develop innovative strategies for improvement. By staying abreast of industry trends and best practices, I am able to implement evidence-based solutions that drive meaningful changes. in the health care industries.
